| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Drugs Made In America Acquisition Corp.
13D
DMAA · G2847J104
|
12.5% |
3/3/2025
Event 2/18/2025
|
||||
| Drugs Made In America Acquisition LLC | 12.5% | |||||
| Lynn Stockwell | 12.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.